157 related articles for article (PubMed ID: 30964016)
21. Centrifugally concentric ring-patterned drug-loaded polymeric coating as an intraocular lens surface modification for efficient prevention of posterior capsular opacification.
Lu D; Han Y; Liu D; Chen S; Qie J; Qu J; Lin Q
Acta Biomater; 2022 Jan; 138():327-341. PubMed ID: 34800717
[TBL] [Abstract][Full Text] [Related]
22. Initial Leuprolide Acetate Release from Poly(d,l-lactide-
Li Z; Mu H; Larsen SW; Jensen H; Østergaard J
Mol Pharm; 2020 Dec; 17(12):4522-4532. PubMed ID: 33164519
[TBL] [Abstract][Full Text] [Related]
23. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
[TBL] [Abstract][Full Text] [Related]
24. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).
Lemoine D; Francois C; Kedzierewicz F; Preat V; Hoffman M; Maincent P
Biomaterials; 1996 Nov; 17(22):2191-7. PubMed ID: 8922605
[TBL] [Abstract][Full Text] [Related]
25. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
Chowdhury DK; Mitra AK
Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
[TBL] [Abstract][Full Text] [Related]
27. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
[TBL] [Abstract][Full Text] [Related]
29. Oligodepsipeptide (nano)carriers: Computational design and analysis of enhanced drug loading.
Brunacci N; Neffe AT; Wischke C; Naolou T; Nöchel U; Lendlein A
J Control Release; 2019 May; 301():146-156. PubMed ID: 30885615
[TBL] [Abstract][Full Text] [Related]
30. Novel bioresorbable stent coating for drug release in congenital heart disease applications.
Goodfriend AC; Welch TR; Barker G; Ginther R; Riegel MS; Reddy SV; Wang J; Nugent A; Forbess J
J Biomed Mater Res A; 2015 May; 103(5):1761-70. PubMed ID: 25196819
[TBL] [Abstract][Full Text] [Related]
31. In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems.
Chen S; Singh J
Pharm Dev Technol; 2005; 10(2):319-25. PubMed ID: 15926681
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of poly(ethylene glycol)-poly(D,L-lactide-co-glycolide) poly(ethylene glycol) tri-block co-polymers modified with collagen: a model surface suitable for cell interaction.
Porjazoska A; Yilmaz OK; Baysal K; Cvetkovska M; Sirvanci S; Ercan F; Baysal BM
J Biomater Sci Polym Ed; 2006; 17(3):323-40. PubMed ID: 16689018
[TBL] [Abstract][Full Text] [Related]
33. Development of microparticles for controlled release of resveratrol to adipose tissue and the impact of drug loading on particle morphology and drug release.
Isely C; Hendley MA; Murphy KP; Kader S; Annamalai P; Jabbari E; Gower RM
Int J Pharm; 2019 Sep; 568():118469. PubMed ID: 31265884
[TBL] [Abstract][Full Text] [Related]
34. Preparation of dexamethasone ophthalmic implants: a comparative study of in vitro release profiles.
Prata AI; Coimbra P; Pina ME
Pharm Dev Technol; 2018 Mar; 23(3):218-224. PubMed ID: 28300463
[TBL] [Abstract][Full Text] [Related]
35. Often neglected: PLGA/PLA swelling orchestrates drug release: HME implants.
Bode C; Kranz H; Fivez A; Siepmann F; Siepmann J
J Control Release; 2019 Jul; 306():97-107. PubMed ID: 31150749
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer.
Jeong YI; Kim DH; Chung CW; Yoo JJ; Choi KH; Kim CH; Ha SH; Kang DH
Int J Nanomedicine; 2011; 6():1415-27. PubMed ID: 21796244
[TBL] [Abstract][Full Text] [Related]
37. Ultrahigh verapamil-loaded controlled release polymeric beads using superamphiphobic substrate: D-optimal statistical design, in vitro and in vivo performance.
Yousry C; Amin MM; Elshafeey AH; El Gazayerly ON
Drug Deliv; 2018 Nov; 25(1):1448-1460. PubMed ID: 29902922
[TBL] [Abstract][Full Text] [Related]
38. Electro-responsive macroporous polypyrrole scaffolds for triggered dexamethasone delivery.
Seyfoddin A; Chan A; Chen WT; Rupenthal ID; Waterhouse GI; Svirskis D
Eur J Pharm Biopharm; 2015 Aug; 94():419-26. PubMed ID: 26141345
[TBL] [Abstract][Full Text] [Related]
39. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
[TBL] [Abstract][Full Text] [Related]
40. [Preparation and in-vitro degradation of polylactide and poly(L-lactide-co-glycolide)].
Wei Z; Liu L; Zhang M; Yang F; Qi M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):122-6. PubMed ID: 18435272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
